Joo-In Park Selected Research

Joo-In Park Research Topics

Disease

18	Neoplasms (Cancer) 04/2020 - 10/2004
10	Leukemia 04/2018 - 01/2007
8	Colorectal Neoplasms (Colorectal Cancer) 02/2020 - 01/2009
2	Carcinogenesis 03/2015 - 04/2007
2	Hepatocellular Carcinoma (Hepatoma) 10/2013 - 10/2004
1	Adenocarcinoma 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Breast Neoplasms (Breast Cancer) 04/2018
1	Lymphatic Metastasis 04/2018
1	Neoplasm Metastasis (Metastasis) 04/2018
1	Inflammation (Inflammations) 01/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2016
1	Hemoglobinopathies 10/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2009
1	Abnormal Karyotype 06/2009
1	Acute Promyelocytic Leukemia 02/2007
1	Necrosis 10/2004

Drug/Important Bio-Agent (IBA)

5	COUP Transcription Factor IIIBA 04/2020 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 10/2017 - 10/2004
4	Biological ProductsIBA 04/2018 - 01/2009
4	Biomarkers (Surrogate Marker)IBA 04/2018 - 01/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2018 - 01/2012
3	TriterpenesIBA 11/2016 - 02/2009
3	GlycosidesIBA 11/2016 - 02/2009
3	Phosphotransferases (Kinase)IBA 09/2015 - 10/2004
2	CateninsIBA 02/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 09/2009
2	dihydroceramide desaturaseIBA 04/2018 - 09/2015
2	SphingolipidsIBA 11/2016 - 06/2009
2	CeramidesIBA 11/2016 - 11/2012
2	LipidsIBA 09/2015 - 01/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 11/2007
2	15-deoxyprostaglandin J2IBA 09/2009 - 11/2007
2	Retinoic Acid Receptor alphaIBA 02/2007 - 01/2007
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Gemcitabine FDA Link 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 04/2018
1	AcidsIBA 04/2018
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2018
1	CarcinogensIBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2017
1	EnzymesIBA 12/2017
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2017
1	Sterol Regulatory Element Binding Protein 1IBA 10/2017
1	CholesterolIBA 10/2017
1	Liver X ReceptorsIBA 10/2017
1	Small Interfering RNA (siRNA)IBA 09/2015
1	stichoposide DIBA 09/2015
1	Diazepam Binding InhibitorIBA 03/2015
1	Death Domain ReceptorsIBA 10/2013
1	Emodin (Archin)IBA 10/2013
1	AnthraquinonesIBA 10/2013
1	LigandsIBA 10/2013
1	stichoposideIBA 11/2012
1	Dietary Fats (Dietary Fat)IBA 01/2012
1	acetylcelluloseIBA 10/2011
1	fucoidanIBA 08/2010
1	Polysaccharides (Glycans)IBA 08/2010
1	LuciferasesIBA 06/2010
1	AgarIBA 06/2010
1	Genetic Markers (Genetic Marker)IBA 10/2009
1	Threonine (L-Threonine)FDA Link 09/2009
1	Serine (L-Serine)FDA Link 09/2009
1	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2009
1	Protein Kinases (Protein Kinase)IBA 09/2009
1	frondoside AIBA 02/2009
1	CaspasesIBA 02/2009
1	cucumarioside A2-2IBA 02/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	TNF-Related Apoptosis-Inducing LigandIBA 11/2007
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2007
1	Methyl MethanesulfonateIBA 08/2007
1	Histone Deacetylase InhibitorsIBA 08/2007
1	Alkylating AgentsIBA 08/2007
1	Checkpoint Kinase 1IBA 04/2007
1	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2007
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2004
1	beta-Galactosidase (Lactaid)IBA 10/2004
1	Mitogen-Activated Protein KinasesIBA 10/2004
1	MitogensIBA 10/2004
1	Therapeutic UsesIBA 10/2004
1	p38 Mitogen-Activated Protein KinasesIBA 10/2004

Therapy/Procedure

4	Therapeutics 01/2020 - 11/2007